These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 31106002)

  • 1. MiR-374b re-sensitizes hepatocellular carcinoma cells to sorafenib therapy by antagonizing PKM2-mediated glycolysis pathway.
    Zhang M; Zhang H; Hong H; Zhang Z
    Am J Cancer Res; 2019; 9(4):765-778. PubMed ID: 31106002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endoplasmic reticulum stress promotes sorafenib resistance via miR-188-5p/hnRNPA2B1-mediated upregulation of PKM2 in hepatocellular carcinoma.
    Zhou B; Lu D; Wang A; Cui J; Zhang L; Li J; Fan L; Wei W; Liu J; Sun G
    Mol Ther Nucleic Acids; 2021 Dec; 26():1051-1065. PubMed ID: 34786210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dauricine upregulates the chemosensitivity of hepatocellular carcinoma cells: Role of repressing glycolysis via miR-199a:HK2/PKM2 modulation.
    Li W; Qiu Y; Hao J; Zhao C; Deng X; Shu G
    Food Chem Toxicol; 2018 Nov; 121():156-165. PubMed ID: 30171973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA MAGI2-AS3 inhibits hepatocellular carcinoma cell proliferation and migration by targeting the miR-374b-5p/SMG1 signaling pathway.
    Yin Z; Ma T; Yan J; Shi N; Zhang C; Lu X; Hou B; Jian Z
    J Cell Physiol; 2019 Aug; 234(10):18825-18836. PubMed ID: 30924168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-21 mediates sorafenib resistance of hepatocellular carcinoma cells by inhibiting autophagy via the PTEN/Akt pathway.
    He C; Dong X; Zhai B; Jiang X; Dong D; Li B; Jiang H; Xu S; Sun X
    Oncotarget; 2015 Oct; 6(30):28867-81. PubMed ID: 26311740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A microRNA-7/growth arrest specific 6/TYRO3 axis regulates the growth and invasiveness of sorafenib-resistant cells in human hepatocellular carcinoma.
    Kabir TD; Ganda C; Brown RM; Beveridge DJ; Richardson KL; Chaturvedi V; Candy P; Epis M; Wintle L; Kalinowski F; Kopp C; Stuart LM; Yeoh GC; George J; Leedman PJ
    Hepatology; 2018 Jan; 67(1):216-231. PubMed ID: 28833396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FAM188B promotes the growth, metastasis, and invasion of hepatocellular carcinoma by targeting the hnRNPA1/PKM2 axis.
    Mu M; Lu Y; Tu K; Tu L; Guo C; Li Z; Zhang X; Chen Y; Liu X; Xu Q; Huang D; Li X
    Biochim Biophys Acta Mol Cell Res; 2024 Oct; 1871(7):119773. PubMed ID: 38844182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PKM2 is the target of proanthocyanidin B2 during the inhibition of hepatocellular carcinoma.
    Feng J; Wu L; Ji J; Chen K; Yu Q; Zhang J; Chen J; Mao Y; Wang F; Dai W; Xu L; Wu J; Guo C
    J Exp Clin Cancer Res; 2019 May; 38(1):204. PubMed ID: 31101057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. circFN1 Mediates Sorafenib Resistance of Hepatocellular Carcinoma Cells by Sponging miR-1205 and Regulating E2F1 Expression.
    Yang C; Dong Z; Hong H; Dai B; Song F; Geng L; Lu J; Yang J; Sui C; Xu M
    Mol Ther Nucleic Acids; 2020 Dec; 22():421-433. PubMed ID: 33230446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-1226-3p Promotes Sorafenib Sensitivity of Hepatocellular Carcinoma via Downregulation of DUSP4 Expression.
    Chen X; Tan W; Li W; Li W; Zhu S; Zhong J; Shang C; Chen Y
    J Cancer; 2019; 10(12):2745-2753. PubMed ID: 31258782
    [No Abstract]   [Full Text] [Related]  

  • 11. Sorafenib-Induced Autophagy Promotes Glycolysis by Upregulating the p62/HDAC6/HSP90 Axis in Hepatocellular Carcinoma Cells.
    Yan X; Tian R; Sun J; Zhao Y; Liu B; Su J; Li M; Sun W; Xu X
    Front Pharmacol; 2021; 12():788667. PubMed ID: 35250553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-128-3p overexpression sensitizes hepatocellular carcinoma cells to sorafenib induced apoptosis through regulating DJ-1.
    Guo XL; Wang HB; Yong JK; Zhong J; Li QH
    Eur Rev Med Pharmacol Sci; 2018 Oct; 22(20):6667-6677. PubMed ID: 30402839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The epigenetically regulated miR-494 associates with stem-cell phenotype and induces sorafenib resistance in hepatocellular carcinoma.
    Pollutri D; Patrizi C; Marinelli S; Giovannini C; Trombetta E; Giannone FA; Baldassarre M; Quarta S; Vandewynckel YP; Vandierendonck A; Van Vlierberghe H; Porretti L; Negrini M; Bolondi L; Gramantieri L; Fornari F
    Cell Death Dis; 2018 Jan; 9(1):4. PubMed ID: 29305580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-122 Targets SerpinB3 and Is Involved in Sorafenib Resistance in Hepatocellular Carcinoma.
    Turato C; Fornari F; Pollutri D; Fassan M; Quarta S; Villano G; Ruvoletto M; Bolondi L; Gramantieri L; Pontisso P
    J Clin Med; 2019 Feb; 8(2):. PubMed ID: 30717317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. circFOXM1 contributes to sorafenib resistance of hepatocellular carcinoma cells by regulating MECP2 via miR-1324.
    Weng H; Zeng L; Cao L; Chen T; Li Y; Xu Y; Peng Y; Ye Y
    Mol Ther Nucleic Acids; 2021 Mar; 23():811-820. PubMed ID: 33614231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In Hepatocellular Carcinoma miR-221 Modulates Sorafenib Resistance through Inhibition of Caspase-3-Mediated Apoptosis.
    Fornari F; Pollutri D; Patrizi C; La Bella T; Marinelli S; Casadei Gardini A; Marisi G; Baron Toaldo M; Baglioni M; Salvatore V; Callegari E; Baldassarre M; Galassi M; Giovannini C; Cescon M; Ravaioli M; Negrini M; Bolondi L; Gramantieri L
    Clin Cancer Res; 2017 Jul; 23(14):3953-3965. PubMed ID: 28096271
    [No Abstract]   [Full Text] [Related]  

  • 17. MicroRNA-122 confers sorafenib resistance to hepatocellular carcinoma cells by targeting IGF-1R to regulate RAS/RAF/ERK signaling pathways.
    Xu Y; Huang J; Ma L; Shan J; Shen J; Yang Z; Liu L; Luo Y; Yao C; Qian C
    Cancer Lett; 2016 Feb; 371(2):171-81. PubMed ID: 26655273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Promoter Hypomethylation and miR-145-5p Downregulation- Mediated HDAC11 Overexpression Promotes Sorafenib Resistance and Metastasis of Hepatocellular Carcinoma Cells.
    Wang W; Ding B; Lou W; Lin S
    Front Cell Dev Biol; 2020; 8():724. PubMed ID: 32903337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydroxychloroquine (HCQ) Modulates Autophagy and Oxidative DNA Damage Stress in Hepatocellular Carcinoma to Overcome Sorafenib Resistance via TLR9/SOD1/hsa-miR-30a-5p/Beclin-1 Axis.
    Chen MY; Yadav VK; Chu YC; Ong JR; Huang TY; Lee KF; Lee KH; Yeh CT; Lee WH
    Cancers (Basel); 2021 Jun; 13(13):. PubMed ID: 34203465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physcion increases the sensitivity of hepatocellular carcinoma to sorafenib through miRNA-370/PIM1 axis-regulated glycolysis.
    Pan XP; Jiya BR; Wang F; Lan Z
    World J Gastrointest Oncol; 2023 Aug; 15(8):1400-1411. PubMed ID: 37663938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.